Irritable Bowel Syndrome Market to Witness Growth During the Study Period (2019-32), Estimates DelveInsight | Key Companies – AstraZeneca, Novartis, Takeda, and others

Las Vegas, Nevada, United States DelveInsight’s “Irritable Bowel Syndrome (IBS) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Irritable Bowel Syndrome (IBS), historical and forecasted epidemiology as well as the Irritable Bowel Syndrome (IBS) market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Irritable Bowel Syndrome Overview
Irritable Bowel Syndrome is a chronic, often debilitating, functional gastrointestinal (GI) disorder. It can begin in childhood, adolescence, or adulthood and can resolve unexpectedly for periods throughout an individual’s lifespan, recurring at any age. The condition causes recurrent attacks of abdominal pain or discomfort in association with bowel habits. The most important single risk factors are female sex, younger age, and preceding gastrointestinal infections.

Irritable Bowel Syndrome Epidemiological Insights
●Lovell and Ford conducted a meta-analysis of studies on the epidemiology of irritable Bowel Syndrome and estimated a global prevalence of 11.2% (95% confidence interval, 9.8-12.8%), a rate that has not changed in the last 30 years. Moreover, they found that the odds ratio of Irritable Bowel Syndrome in women has only modestly increased compared with men and that socioeconomic status did not show any effect on prevalence, though there are some conflicting results.
●Globally, Southeast Asia has the lowest prevalence of Irritable Bowel Syndrome (7.0%), and South America has the highest (21.0%). Regrettably, the prevalence in Africa is not clear as there have been few population-based studies. Such studies are needed in countries that lack precise epidemiological data.
Irritable Bowel Syndrome Treatment Market

●The Irritable Bowel Syndrome Treatment Market Size is expected to reach USD 4.7 Billion by 2032.

Leading Companies Working in the Irritable Bowel Syndrome Pipeline
●Redhill Biopharma
●Forest Pharmaceuticals
●Bausch Health
●And many others

Promising Therapies in the Irritable Bowel Syndrome Pipeline
●ORP-101
●TU-100
●Bifidobacterium infantis
●And many others
Learn more about the Irritable Bowel Syndrome key companies and emerging therapies @ Irritable Bowel Syndrome Therapeutics Market Analysis

Scope of the Irritable Bowel Syndrome Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan]
Key Irritable Bowel Syndrome Companies: Redhill Biopharma, Forest Pharmaceuticals, Inc., Bausch Health, and many others.
Key Irritable Bowel Syndrome Pipeline Therapies: ORP-101, TU-100, Bifidobacterium infantis, and many others.
Therapeutic Assessment: Irritable Bowel Syndrome current marketed and emerging therapies
Irritable Bowel Syndrome Market Dynamics: Irritable Bowel Syndrome market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Irritable Bowel Syndrome Market Access and Reimbursement

Table of Contents
1. Irritable Bowel Syndrome Market Key Insights
2. Irritable Bowel Syndrome Market Report Introduction
3. Irritable Bowel Syndrome Market Overview at a Glance
4. Irritable Bowel Syndrome Market Executive Summary
5. Disease Background and Overview
6. Irritable Bowel Syndrome Treatment and Management
7. Irritable Bowel Syndrome Epidemiology and Patient Population
8. Patient Journey
9. Irritable Bowel Syndrome Emerging Drugs
10.7MM Irritable Bowel Syndrome Market Analysis
11. Irritable Bowel Syndrome Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Irritable Bowel Syndrome Market Drivers
15. Irritable Bowel Syndrome Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19.DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Download the sample pages @ Irritable Bowel Syndrome Market Outlook

Trending Reports
‘Food Allergy Market Insights, Epidemiology, and Market Forecast—2032’
Postoperative Pain Market Insights, Epidemiology, and Market Forecast – 2032

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us
Adya Kaul
+1(919)321-6187
info@delveinsight.com
www.delveinsight.com